Ipamorelin Peptide Guide

Ipamorelin is a synthetic peptide studied as a selective growth-hormone secretagogue. This page explains what it is and how clinician-supervised programs through ElliotMeds work. It is educational and not medical advice.

Last updated: July 2, 2026

What Is Ipamorelin?

Ipamorelin is a synthetic peptide that acts as an agonist at the ghrelin/growth-hormone-secretagogue receptor and has been studied for selective GH release. It is not FDA-approved for general wellness, anti-aging, bodybuilding, or recovery support.

How It Works

Ipamorelin is designed to stimulate GH release through the GH-secretagogue receptor; early research describes it as relatively selective for GH release compared with some older secretagogues. It is not described as a proven way to build muscle, lose fat, improve sleep, or reverse aging.

What It’s Studied For

Ipamorelin has pharmacology research around GH secretion and preclinical research in areas such as gastrointestinal motility. Human outcome data for common wellness claims remain limited, and the FDA has identified compounded ipamorelin acetate as raising immunogenicity, impurity, and characterization concerns. It is not FDA-approved for these uses.

What to Expect

Use is framed only as provider-directed; no outcome or timeline is promised, and results are individual and unverified for these purposes.

Preferred Starting Options / Dosing Notes

Many patients begin with a lower starting option so a licensed clinician can evaluate tolerance, medical history, goals, and safety factors before any adjustments are considered. The starting option shown below is informational and reflects available program data, not self-directed dosing instructions. Final medication, dose, frequency, and treatment plan are determined by a licensed clinician.

Safety Considerations

• Reported effects include injection-site reactions, headache, flushing, water retention, and appetite changes, with possible glucose effects and unknown long-term safety for off-label wellness use.
• Purity and sterility matter for any injectable peptide.
• No peptide is "safe" without qualification.

Who Is Not a Candidate

A clinician reviews goals, IGF-1/GH considerations, metabolic and glucose status, cancer history, edema/fluid retention, sleep apnea, and medications before considering use, and may determine it is not appropriate; pregnancy/breastfeeding warrant particular caution.

How It Compares

Ipamorelin acts only at the GH-secretagogue receptor; the CJC-1295/Ipamorelin blend adds a GHRH-analog component; sermorelin is a separate GHRH-pathway peptide. None is presented as superior.

Frequently Asked Questions

References

• Peer-reviewed pharmacology literature on ipamorelin (PubMed)
• FDA compounding-safety communications on ipamorelin acetate